After-Hours Stock Movers 11/14: (EQY) (RPRX) (AAP) Higher; (SYN) (GEVO) (TSRO) Lower (more...)
- Wall St. stock futures fall after Italy referendum
- Oil tops $55 for first time in 16 months as OPEC deal fuels buying
- Consolidated Communications (CNSL) to Acquire FairPoint Communications (FRP) in $1.5B Deal
- Burberry rejects multiple takeover offers from Coach: Financial Times
- Trump picks ex-rival Carson to head housing department
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Today's After-Hours Movers
Synthetic Biologics, Inc. (NYSE: SYN) 18.9% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Equity One, Inc. (NYSE: EQY) 14.8% HIGHER; Regency Centers Corporation (NYSE: REG) and Equity One, Inc. (NYSE: EQY) announced that they have entered into a definitive merger agreement under which Equity One will merge with and into Regency, with Regency continuing as the surviving public company and creating the preeminent shopping center Real Estate Investment Trust (“REIT”). The resulting enterprise will have industry-leading operating, development, redevelopment capacities as well as an unparalleled portfolio of primarily grocery-anchored properties uniquely positioned to sustain growth in net operating income (“NOI”) and create value for all of its stakeholders. The combined company is expected to have a pro forma equity market capitalization of approximately $11.7 billion and a total market capitalization of $15.6 billion, making it the largest REIT by equity value in the shopping center index.
Repros Therapeutics Inc. (Nasdaq: RPRX) 14.4% HIGHER; reported the topline results for both its pooled oral and vaginal delivery Phase 2 studies in the treatment of uterine fibroids. Both studies enrolled women with confirmed fibroids by MRI at baseline and who were experiencing more than 80 mL of blood loss during menses as confirmed by alkaline hematin assessment. Proellex® at doses of both 6 and 12 mg, delivered by either route, substantially and significantly reduced excessive menstrual bleeding, the key symptom of uterine fibroids and the primary endpoint of the studies. The study of vaginal delivery enrolled 42 subjects and the oral delivery studys intent-to-treat population included 41 subjects.
Advance Auto Parts (NYSE: AAP) 13.4% HIGHER; reported Q3 EPS of $1.73, $0.02 better than the analyst estimate of $1.71. Revenue for the quarter came in at $2.25 billion versus the consensus estimate of $2.2 billion. Comps fell 1 percent versus an estimated 3.5 percent drop.
Gevo (NASDAQ: GEVO) 10.6% LOWER; reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $9.12 million.
Amplify Snack Brands (NYSE: BETR) 9.8% LOWER; reported Q3 EPS of $0.12, $0.03 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $68 million versus the consensus estimate of $65.17 million. GUIDANCE: Amplify Snack Brands sees FY2016 EPS of $0.49-$0.51, versus the consensus of $0.61. Amplify Snack Brands sees FY2016 revenue of $268-272 million, versus the consensus of $267.9 million.
TESARO, Inc. (NASDAQ: TSRO) 6.3% LOWER; announced today that it has commenced an underwritten public offering of 1,750,000 shares of its common stock.
Alarm.com Holdings, Inc. (NASDAQ: ALRM) 5.5% HIGHER; reported Q3 EPS of $0.19, $0.08 better than the analyst estimate of $0.11. Revenue for the quarter came in at $67.8 million versus the consensus estimate of $59.73 million. Alarm.com Holdings, Inc. sees FY2016 EPS of $0.58-$0.59, versus the consensus of $0.50. Alarm.com Holdings, Inc. sees FY2016 revenue of $245-256 million, versus the consensus of $245.2 million.
Pier 1 Imports, Inc. (NYSE: PIR) 4.5% HIGHER; updated its third quarter fiscal 2017 financial guidance to reflect recent business trends. Expect fiscal third quarter results to be at the high-end of our previously guided ranges for comparable and net sales, merchandise margin, earnings per share and adjusted earnings per share
American Airlines (NASDAQ: AAL) 4% HIGHER; Warren Buffett's Berkshire Hathaway shows new 21,770,555 share position.
Zoe's Kitchen (NYSE: ZOES) 3.7% LOWER; reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $67.3 million versus the consensus estimate of $68.04 million. Comparable restaurant sales increased 2.4%. GUIDANCE: Zoe's Kitchen sees FY2016 revenue of $276 - $277 million, versus prior guidance of $277 - $280 million and the consensus of $277.6 million. Comparable restaurant sales growth of 4.0% to 4.5% (previously 4.0% to 5.0%).
Southwest Airlines (NYSE: LUV) 3.3% HIGHER; Warren Buffett's Berkshire Hathaway has a new stake, although not disclosed in 13F, according to CNBC.
Extended Stay America (NYSE: STAY) 3.3% LOWER; Extended Stay America, Inc. and ESH Hospitality, Inc. (NYSE: STAY) announced an underwritten secondary offering (the offering) of 12,750,000 Paired Shares, each Paired Share consisting of a share of common stock of Extended Stay America, Inc. and a share of Class B common stock of ESH Hospitality, Inc., which are attached and trade together as Paired Shares, by certain selling stockholders affiliated with Centerbridge Partners, L.P., Paulson & Co. Inc. and The Blackstone Group L.P. (the Selling Stockholders).
Delta Air Lines (NYSE: DAL) 3.2% HIGHER; Warren Buffett's Berkshire Hathaway shows new 6,333,923 share position
United Continental (NYSE: UAL) 2.2% HIGHER; Warren Buffett's Berkshire Hathaway new 4,533,013 share position
AngioDynamics, Inc. (NASDAQ: ANGO) 2% LOWER; announced that certain of its stockholders (intend to offer for sale in an underwritten secondary offering 2,500,000 shares of common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission, of which the Company intends to repurchase from the underwriter 500,000 shares of common stock. The Selling Stockholders will receive all of the net proceeds from this offering. No shares are being sold by the Company. Barclays Capital Inc. will act as underwriter for the offering.
HCA (NYSE: HCA) 1.5% HIGHER; announced that its Board of Directors has authorized an additional share repurchase program for up to $2 billion of the Company’s outstanding common stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caterpillar (CAT) Offers FY17 Guidance Update at Credit Suisse Conference
- Notable Mergers and Acquisitions 12/2: (VASC)/(TFX) (TWTR) (III) (BSX)/(NVCN)
- Pandora (P) Advisers Said to Begin Reaching Out to Possible Suitors Following Approach from Sirius (SIRI) - Bloomberg
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesWarren Buffett, Paulson & Co. (PCI), Barclays, After-Hours Movers, Permira, Earnings, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!